which then gives a first market for any biotech company. And then you can go global from there. Is there far too much uncertainty about the protection of your IP in India? I think the situation ...

Bharat Biotech is ready to adapt its intranasal and injectable covid vaccines for new variants as India reports 5,755 active ...

BENGALURU, Aug 18 (Reuters) - Shares of India's Concord Biotech (CONB.NS), opens new tab settled 27.2% higher at 942.8 rupees in their trading debut on Friday, valuing the biopharma company at ...

and Converge Biotech, a prominent healthcare company with a strong critical care and infectious disease focus in India, are pleased to announce a new strategic collaboration where the two ...